Roche Holding (Switzerland) Today
| RO Stock | CHF 269.60 3.80 1.43% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Roche Holding is selling for under 269.60 as of the 25th of November 2024; that is 1.43 percent increase since the beginning of the trading day. The stock's lowest day price was 265.8. Roche Holding has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Roche Holding AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. The company has 106.69 M outstanding shares. More on Roche Holding AG
Moving together with Roche Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Roche Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Roche Holding's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Roche Holding or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Roche Holding AG (RO) is traded on SIX Swiss Exchange in Switzerland and employs 103,613 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 223.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Roche Holding's market, we take the total number of its shares issued and multiply it by Roche Holding's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Roche Holding AG classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 106.69 M outstanding shares.
Roche Holding AG has accumulated about 2.15 B in cash with 18.41 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5.
Check Roche Holding Probability Of Bankruptcy
Ownership AllocationRoche Holding owns a total of 106.69 Million outstanding shares. Roche Holding holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.31 pct. of Roche Holding AG outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Roche Ownership Details
Roche Holding AG Risk Profiles
Although Roche Holding's alpha and beta are two of the key measurements used to evaluate Roche Holding's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8867 | |||
| Standard Deviation | 1.12 | |||
| Variance | 1.25 | |||
| Risk Adjusted Performance | (0.12) |
Roche Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Roche Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Roche Holding Corporate Management
Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claudia Bockstiegel | G Counsel | Profile | |
| Barbara Schadler | Head Communications | Profile | |
| Johannes MD | Head Devel | Profile | |
| Bruno Eschli | Head Relations | Profile | |
| Thomas Schinecker | Chief Diagnostics | Profile | |
| Cristina Wilbur | Chief Officer | Profile | |
| William Anderson | Chief Pharmaceuticals | Profile |
Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.